Years of Corporate History
Global Offices
Global Clients
Products Registration Support Annually
As the leading medical device CRO in China,Tigermed-Jyton offers the full life cycle service and global expertise in all stages of the product development process. With our rich project experience and strong professionalism, our dedicated team is committed to offering optimized solutions that aim fast-track commercialization of your product, reducing project risks while achieving cost-efficient outcomes.
Tigermed-Jyton has accumulated a large customer base and rich product experience while assisting in developing some products with cutting-edge technologies. We have provided services to many medical device companies and established advantages in multiple areas including oncology, orthopedics, cardiovascular, ophthalmology, medical aesthetics, artificial intelligence, stomatology, and more.
BEIJING, CHINA and TOLEDO, US –February 29, 2024—Tigermed-Jyton, a leading medical device CRO in China, and NAMSA, a global leader MedTech Contract Research Organization (CRO) offering global end-to-end development services, today announced Tigermed-Jyton’s acquisition of NAMSA China, as well as the exclusive China region partnership and global collaboration between Tigermed-Jyton and NAMSA.